ciclopirox has been researched along with sphingosine 1-phosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aref, AR; Kamm, RD; Kim, C; Lim, SH; Raghunath, M | 1 |
1 other study(ies) available for ciclopirox and sphingosine 1-phosphate
Article | Year |
---|---|
Complementary effects of ciclopirox olamine, a prolyl hydroxylase inhibitor and sphingosine 1-phosphate on fibroblasts and endothelial cells in driving capillary sprouting.
Topics: Chemokine CCL2; Ciclopirox; Computer Simulation; Endothelial Cells; Fibroblasts; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lysophospholipids; Microfluidics; Neovascularization, Physiologic; Prolyl-Hydroxylase Inhibitors; Proteomics; Pyridones; Sphingosine; Vascular Endothelial Growth Factor A | 2013 |